OMX Nordic 40
|
2 647,79
|
36,38
|
1,39 %
|
Analysen zu OMX Nordic 40-Werten
| 08.01.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 07.01.26 | Volvo AB Market-Perform | Bernstein Research | |
| 07.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 06.01.26 | ABB Market-Perform | Bernstein Research | |
| 06.01.26 | ABB Underweight | Barclays Capital | |
| 06.01.26 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 06.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Ericsson Underperform | Bernstein Research | |
| 05.01.26 | Nokia Market-Perform | Bernstein Research | |
| 19.12.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 18.12.25 | ABB Hold | Jefferies & Company Inc. | |
| 17.12.25 | ABB Sector Perform | RBC Capital Markets | |
| 16.12.25 | Volvo AB Buy | UBS AG | |
| 16.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 12.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.12.25 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 12.12.25 | Novo Nordisk Neutral | UBS AG | |
| 11.12.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 09.12.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.12.25 | Volvo AB Hold | Deutsche Bank AG | |
| 08.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.12.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.12.25 | AstraZeneca Outperform | Bernstein Research | |
| 04.12.25 | Novo Nordisk Neutral | UBS AG | |
| 04.12.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 02.12.25 | Volvo AB Outperform | RBC Capital Markets | |
| 01.12.25 | Novo Nordisk Neutral | UBS AG | |
| 01.12.25 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 01.12.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.12.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.11.25 | Novo Nordisk Equal Weight | Barclays Capital |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 1 |
| Novo Nordisk | 1 |
| Volvo AB | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.